2016 Speaking Faculty

Malin Akerfelt, Ph.D., Senior Research Scientist, High-Content Screening Laboratory, Institute of Biomedicine, University of Turku

Paul Andrews, Ph.D., Director, National Phenotypic Screening Centre, University of Dundee, UK

Ulrich Broeckel, M.D., Professor, Pediatrics, Medical College of Wisconsin

Steven Chi-Ming Chen, Specialist, Pharmaceutical Chemistry, Small Molecule Discovery Center at UCSF, Mission Bay

Anthony M. Davies, Ph.D., Center Director, Translational Cell Imaging Queensland (TCIQ), Institute of Health Biomedical Innovation, Queensland University of Technology

Mohanraj Dhanabal, Ph.D., Group Leader, Lead Discovery Technology, EMD Serono

Regis Doyonnas, Ph.D., Senior Principal Scientist, High-Content Screening and HTS-Flow Cytometry, Primary Pharmacology Group, Pfizer

Lauren Drowley, Ph.D., Associate Principal Scientist, AstraZeneca

Su Guo, Ph.D., Professor, Bioengineering and Therapeutic Sciences, University of California, San Francisco

Erik Hett, Ph.D., Team Leader, Senior Scientist, Chemical & Molecular Therapeutics, Biogen

Susanne Heynen-Genel, Ph.D., Director, High-Content Screening Systems, Sanford Burnham Prebys Medical Discovery Institute

Charles C. Hong, M.D., Ph.D., Associate Professor, Cardiovascular Medicine, Pharmacology, and Cell & Developmental Biology, Vanderbilt University School of Medicine

Shane Horman, Ph.D., Research Investigator, Advanced Assays, Genomics Institute of the Novartis Research Foundation

Tae-Wan Kim, Ph.D., Associate Professor, Department of Pathology & Cell Biology, Columbia University Medical Center

Fred King, Ph.D., Research Investigator, Novartis Institute for BioMedical Research

Beatrice Knudsen, M.D., Ph.D., Director, Translational Pathology, Cedars Sinai Medical Center

Daniel V. LaBarbera, Ph.D., Associate Professor, Drug Discovery and Medicinal Chemistry, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado

Madhu Lal-Nag, Ph.D., Acting Team Lead, RNAi Screening Facility, National Center for Advancing Translational Sciences, National Institutes of Health

Ming Lei, Senior Scientist, Lead Discovery & Optimization, Bristol-Myers Squibb

Vance Lemmon, Ph.D., Professor and Chair, Developmental Neuroscience, The Miami Project to Cure Paralysis, University of Miami

Zhuyin Li, Ph.D., Translational Biomarker Team Lead, Lead Discovery & Optimization, Bristol-Myers Squibb

David J. Logan, Ph.D., Computational Biologist, Imaging Platform, Broad Institute of Harvard and MIT

Lisa Minor, Ph.D., President, In V itro Strategies, LLC

Mary-Ann Mycek, Ph.D., Professor and Associate Chair for Translational Research, Department of Biomedical Engineering, College of Engineering & Medical School, University of Michigan

Imran Rizvi, Ph.D., Instructor, Medicine and Dermatology, Brigham and Women’s Hospital, Massachusetts General Hospital, Harvard Medical School

Nathan Ross, Ph.D., Senior Investigator, High Throughput Biology Group Leader, Novartis Institutes for BioMedical Research

Krishanu Saha, Ph.D., Assistant Professor, Biomedical Engineering, University of Wisconsin, Madison

Jeff Saucerman, Ph.D., F.A.H.A., Associate Professor, Biomedical Engineering, University of Virginia

Enrico Schmidt, Ph.D., Lab Head and Investigator, Center for Proteomic Chemistry, Integrated Lead Discovery, Novartis Pharma AG

Ulrich Schopfer, Ph.D., Executive Director and Head, Integrated Lead Discovery, Novartis Institutes for BioMedical Research

Mark Schurdak, Ph.D., Research Associate Professor, Computational and Systems Biology, University of Pittsburgh; Director, Drug Discovery Institute

D. Lansing Taylor, Ph.D., Director, University of Pittsburgh Drug Discovery Institute and Allegheny Foundation Professor, Computational and Systems Biology, University of Pittsburgh

Andreas Vogt, Ph.D., Associate Professor, Computational and Systems Biology, University of Pittsburgh

Alan Waggoner, Ph.D., Professor, Biological Sciences, and Director, Molecular Biosensor and Imaging Center, Carnegie Mellon University

Wei Zheng, Ph.D., Group Leader, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health